PING Conference 2024

AI in Pharma - Threat or opportunity?

AI is currently dominating discussions. It has already changed how we operate and is poised to significantly reshape the world. McKinsey's research points to potential opportunities worth $100 billion annually for the pharmaceutical industry. However, alongside these opportunities come significant threats and risks. AI's influence will impact every aspect of the pharmaceutical ecosystem, spanning from drug discovery and repurposing to sourcing, manufacturing, quality assurance, supply chain management, and engagement with healthcare professionals and patients.

Consequently, AI in pharma is an unavoidable subject. At this year's PING Conference, attendees will have the chance to learn from industry experts who will delve into the practical implications of AI in pharma. Covering insightful case studies, delegates will hear about both risks and opportunities leaving them better placed to face and prepare for what is coming.

This year, the event is being hosted in the beautiful grounds of Knebworth House and Barns, just outside the Stevenage science park. There will be plenty of opportunities to network with other industry players. Following the afternoon sessions, enjoy outside drinks in the venue's picturesque grounds, and then a relaxed evening with entertainment that promises to bring some magic to the day, and dinner.

What topics will be covered?

Overview of AI in Pharma - What is happening in the AI world in Pharma: drug discovery to sourcing, manufacturing, quality, supply chain and engagement with healthcare professionals and patients?
AI in drug discovery and product development - A cutting edge panel looking at using AI in drug discovery and repurposing.
AI and personalised medicine - Using AI to accurately predict a patient's response to treatment and allocate them to pathways. Combining genomic data, imaging profiles, and clinical information in a manner previously impossible.
The risks and ethical concerns of using AI - What data hazards and ethical issues are there, such as data bias and inaccurate data?
AI solving healthcare disparities - Using AI as a force for good.
Using AI - Is it legal? - From copyright in training material to data protection issues, has the law kept pace with technology?
Intelligent use of AI - Getting the most out of market and product data using AI - and using AI to track your competitors' moves.
Intelligent management of your supply chain - how to get AI to improve your knowledge, reduce your costs and improve efficiency in your supply chains.

Who is joining us?

This year, PING 2024 will hear from an impressive lineup of industry experts hailing from major players in the field of AI in Pharma. This includes:

Philip Ashton - Co-founder and CEO - 7bridges
Nicola Richmond - VP of AI - BenevolentAI
James Turnbull - Founder - Camino Communications
Gareth Langley - Research Leader - Charles River Laboratories
Dr. Sola Adeleke - Founder and CEO - Curenetics
Dr. Andrée Bates - CEO/Founder/Chairman - Eularis
Dr. Rav Seeruthun - Chief Medical Officer - health-equity.ai
Nick Street - Head of Operations, People and Tech - Healx
Jordan Lane - Chief Scientific Officer - Ignota Labs
Darren Spevick - Founder and Managing Director - Russell Strategy Partners
Harry Jennings - Life Sciences Partner - VWV

Please note, these speakers may be subject to change.

If you're viewing on a mobile/tablet and looking for date, pricing and venue information please click the 'More in this section' tab at the top of this page.